ACADIA Pharmaceuticals
ACAD
#4034
Rank
A$4.46 B
Marketcap
A$25.85
Share price
-2.73%
Change (1 day)
-29.14%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): A$0.22 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.20 Billion. In 2025 the company made an earning of A$0.20 Billion a decrease over its 2024 earnings that were of A$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.22 B8.69%
2025 A$0.20 B-46.18%
2024 A$0.38 B-605.67%
2023 -A$77.11 Million-76.09%
2022 -A$0.33 Billion27.41%
2021 -A$0.26 Billion-40.38%
2020 -A$0.43 Billion19.88%
2019 -A$0.36 Billion-3.92%
2018 -A$0.37 Billion-15.04%
2017 -A$0.44 Billion6.33%
2016 -A$0.41 Billion64.55%
2015 -A$0.25 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$57.34 Million81.93%
2012 -A$31.52 Million-8.73%
2011 -A$34.53 Million-251.39%
2010 A$22.8 M-133.2%
2009 -A$68.7 Million-30.82%
2008 -A$99.3 Million6.43%
2007 -A$93.3 Million25.89%
2006 -A$74.11 Million36.99%
2005 -A$54.1 Million37.22%
2004 -A$39.43 Million19.96%
2003 -A$32.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B 11,808.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B 4,332.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.52 B 22,016.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.12 B 7,108.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion-213.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$58.37 Million-124.57%๐Ÿ‡บ๐Ÿ‡ธ USA